|
|
|
|
|
|
|
|
|
|
|
28.05.26 - 18:15
|
EU verhängt Sanktionen gegen israelische Siedler (DPA-AFX)
|
|
|
BRÜSSEL (dpa-AFX) - Die EU hat die angekündigten Sanktionen wegen der Gewalt radikaler israelischer Siedler gegen Palästinenser im Westjordanland verhängt. Die Maßnahmen treffen vier Organisationen und drei Einzelpersonen, wie die Vertretung der Mitgliedstaaten ......
|
|
|
|
|
|
|
28.05.26 - 17:54
|
Wix To Cut About 20% Of Workforce Amid AI Shift (AFX)
|
|
|
JERUSALEM (dpa-AFX) - Website development platform Wix.com Ltd. (WIX) is cutting roughly 20% of its workforce as part of a broad restructuring aimed at adapting to the rapid rise of artificial int......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.05.26 - 14:54
|
Entera′s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation (GlobeNewswire EN)
|
|
|
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts across its oral peptide pipeline have been accepted for presentation at ENDO 2026, the annual meeting of the Endocrine Society, taking place June 13-16, 2026 in Chicago, Illinois, USA. Notably, new clinical data supporting Entera's single EB613 tablet as the final candidate for its planned Phase 3 study in postmenopausal women with osteoporosis was selected for a Late Breaking Oral Presentation....
|
|